Viiv Health Care Stock Symbol

Listing Websites about Viiv Health Care Stock Symbol

Filter Type:

ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance S…

(6 days ago) People also askWho owns ViiV Healthcare?(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi Limited as shareholders, said that the US Food and Drug Administration approved Apretude, long-acting injectable pre-exposure prophylaxis option to reduce the risk of sexually acquired HIV-1.ViiV Healthcare : FDA Approves Apretude, Long-acting Injectable Optio…markets.businessinsider.comWhat is ViiV Healthcare's market share?ViiV Healthcare's products have a market share of approximately 32% of the global HIV therapy market, making it the second-largest healthcare company in the sector, after Gilead Sciences.ViiV Healthcare - Wikipediaen.wikipedia.orgDoes ViiV Healthcare have a co-ownership structure?According to The Financial Times, the company’s co-ownership structure may change depending on the achievement of certain milestones. ViiV Healthcare's products have a market share of approximately 32% of the global HIV therapy market, making it the second-largest healthcare company in the sector, after Gilead Sciences.ViiV Healthcare - Wikipediaen.wikipedia.orgWhat's new at ViiV Healthcare?Kimberly Smith, M.D., MPH, Head of Research & Development at ViiV Healthcare, said: "As leaders in developing long-acting injectables for the treatment of HIV, we’re excited to present new data setting the stage for ViiV’s next generation of medicines and demonstrating how key pipeline assets will target HIV in different ways.ViiV Healthcare to present data for its next generation of ultra long finance.yahoo.comFeedbackBloomberghttps://www.bloomberg.com/profile/company/3452591Z:LNViiV Healthcare Ltd - Company Profile and NewsWEBCompany profile page for ViiV Healthcare Ltd including stock price, company news, executives, board members, and contact information

https://seekingalpha.com/article/3452586-viiv-healthcare-hidden-gem-of-glaxosmithklines-balance-sheet#:~:text=ViiV%20Healthcare%20is%20a%20consolidated%20division%20of%20GlaxoSmithKline,treatment%20and%20care%20for%20people%20living%20with%20HIV.

Category:  Food,  Medicine Show Health

ViiV Healthcare announces U.S. FDA approval of Dovato …

(7 days ago) WEBDURHAM, N.C., April 08, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the U.S. …

https://finance.yahoo.com/news/viiv-healthcare-announces-u-fda-122300021.html

Category:  Health Show Health

GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With …

(Just Now) WEBViiV Healthcare, majority-owned by GSK Plc (NYSE: GSK), Pfizer Inc (NYSE: PFE), and Shionogi Limited, announced 12-month findings from the SOLAR …

https://finance.yahoo.com/news/gsk-pfizer-backed-viiv-healthcares-154336744.html

Category:  Health Show Health

ViiV Healthcare : FDA Approves Apretude, Long-acting

(2 days ago) WEB(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi …

https://www.nasdaq.com/articles/viiv-healthcare-%3A-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

GlaxoSmithKline's ViiV Healthcare Receives FDA Approval …

(4 days ago) WEBFeb 1, 2022 10:39PM EST. (RTTNews) - ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer and …

https://www.nasdaq.com/articles/glaxosmithklines-viiv-healthcare-receives-fda-approval-for-hiv-treatment

Category:  Health Show Health

ViiV Healthcare - Markets Insider

(5 days ago) WEBViiV Healthcare noted that it will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention-1031058136

Category:  Health Show Health

ViiV Healthcare Announces FDA's Priority Review …

(8 days ago) WEBSep 28, 2021 7:00AM EDT. (RTTNews) - ViiV Healthcare announced the FDA has accepted and granted priority review for a New Drug Application for investigational …

https://www.nasdaq.com/articles/viiv-healthcare-announces-fdas-priority-review-designation-for-cabotegravir-2021-09-28

Category:  Health Show Health

GSK unit ViiV raises outlook on long-term HIV therapies

(Just Now) WEBViiV Healthcare, majority owned by GSK, raises growth outlook on strength of long-acting HIV treatments, with sales projected to grow 6-8% through 2026. Read …

https://seekingalpha.com/news/4016632-gsk-unit-viiv-raises-outlook-long-term-hiv-therapies

Category:  Health Show Health

GSK: ViiV Healthcare Gets FDA Approval For HIV …

(5 days ago) WEB(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) said Friday that its majority-owned specialist HIV company ViiV Healthcare has received approval from the US Food …

https://markets.businessinsider.com/news/stocks/gsk-viiv-healthcare-gets-fda-approval-for-hiv-treatment-cabenuva-quick-facts-1029993099

Category:  Food Show Health

ViiV Healthcare announces FDA approval of two-month dosing of …

(6 days ago) WEBViiV Healthcare, majority-owned by GlaxoSmithKline (GSK), announced that the FDA approved an every-two-month dosing regimen of the company’s HIV therapy …

https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv

Category:  Health Show Health

The Hidden Gem Of GlaxoSmithKline's Balance Sheet - Seeking …

(1 days ago) WEBViiV healthcare is invisible on GSK's balance sheet with a negative net position of contingent consideration outweighing intangible assets by £0.7 BN ($1.1 BN). …

https://seekingalpha.com/article/3452586-viiv-healthcare-hidden-gem-of-glaxosmithklines-balance-sheet

Category:  Health Show Health

ViiV Healthcare announces interim data at CROI indicating …

(8 days ago) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced data from a …

https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/ViiV-Healthcare-announces-interim-data-at-CROI-indicating-superior-efficacy-of-long-acting-injectabl-46111440/

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(9 days ago) WEBViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in …

https://finance.yahoo.com/news/viiv-healthcare-present-data-next-150400807.html

Category:  Health Show Health

ViiV Healthcare - Wikipedia

(5 days ago) WEBViiV Healthcare (/ ˈ v iː v / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent …

https://en.wikipedia.org/wiki/ViiV_Healthcare

Category:  Medicine Show Health

ViiV Healthcare Company Profile 2024: Valuation, Funding

(8 days ago) WEBViiV Healthcare General Information Description. Operator of a global specialist HIV company intended to deliver innovative new options for the care and treatment of people …

https://pitchbook.com/profiles/company/104459-32

Category:  Health Show Health

Glaxo (GSK) Gets FDA Nod for Long-Acting HIV Regimen Cabenuva

(2 days ago) WEBShares of Glaxo have plunged 21% so far this year against the industry’s increase of 6.1%.. ViiV Healthcare is an HIV company, majorly owned by Glaxo and …

https://www.nasdaq.com/articles/glaxo-gsk-gets-fda-nod-for-long-acting-hiv-regimen-cabenuva-2021-01-22

Category:  Health Show Health

ViiV Healthcare Ltd Reuters

(2 days ago) WEBFebruary 22, 2023. 1 to 3 of 3. The latest international ViiV Healthcare Ltd news and views from Reuters - one of the world's largest news agencies.

https://www.reuters.com/company/viiv-healthcare-ltd/

Category:  Health Show Health

ViiV Healthcare inks licensing deal with Shionogi to develop HIV

(2 days ago) WEBViiV and Shionogi intend to initiate first time in human studies with S-365598 by 2023. Recently, FDA granted Priority Review to Viiv Healthcare’s cabotegravir long …

https://seekingalpha.com/news/3745173-viiv-healthcare-inks-licensing-deal-with-shionogi-to-develop-hiv-integrase-inhibitor

Category:  Health Show Health

ViiV Healthcare reports three-year switch data for Dovato in HIV

(2 days ago) WEBSep. 29, 2021 3:20 AM ET GSK plc (GSK) Stock, PFE Stock, SGIOY Stock SGIOF By: SA News Team 2 Comments ViiV Healthcare presents three-year results from the TANGO …

https://seekingalpha.com/news/3745574-viiv-healthcare-reports-three-year-switch-data-for-dovato-in-hiv

Category:  Health Show Health

Validea's Top Health Care Stocks Based On Joseph Piotroski

(9 days ago) WEBThe following are the top rated Health Care stocks according to Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This …

https://www.nasdaq.com/articles/valideas-top-health-care-stocks-based-on-joseph-piotroski-5-12-2024

Category:  Health Show Health

GlaxoSmithKline: 4.57% Dividend Yield, Cure For COVID-19 & HIV

(2 days ago) WEBSales of Sotrovimab for COVID-19 were £114 million in Q3 2021, up 612.5% from Q2 2021. ViiV Healthcare, majority-owned by GlaxoSmithKline, wins litigation …

https://seekingalpha.com/article/4483866-glaxosmithkline-4-57-percent-dividend-yield-cure-covid-19-hiv

Category:  Health Show Health

3 Cheap Healthcare Stocks to Buy Now: May 2024 Nasdaq

(8 days ago) WEBIn terms of full 2024 guidance, the company sees adjusted operational sales growing 5.8% at the midpoint. Furthermore, it expects adjusted diluted EPS to be in the …

https://www.nasdaq.com/articles/3-cheap-healthcare-stocks-to-buy-now:-may-2024

Category:  Health Show Health

Is Novavax Stock a Buy? Nasdaq

(4 days ago) WEBNovavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are …

https://www.nasdaq.com/articles/is-novavax-stock-a-buy

Category:  Health Show Health

Filter Type: